Pheresis: Clinical Trials

7 trials of Pheresis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 active not recruiting, 1 terminated, 1 withdrawn. 7 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Recruiting 3, Active not recruiting 2, Terminated 1, Withdrawn 1
Phase 15Recruiting 2, Active not recruiting 1, Terminated 1, Withdrawn 1

Follow Pheresis: new trials by email Literature Review of Pheresis trials Research Report on Pheresis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Myeloid Leukemia, Acute Undifferentiated Leukemia
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center362025-09-232026-11-19
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2RecruitingCity of Hope Medical Center2162024-07-092026-10-23
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma
Phase 1 / Phase 2Active not recruitingMayo Clinic382023-09-282026-09-21
Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation
Biopsy, Biospecimen Collection, Bone Marrow Biopsy - Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia
Phase 2Active not recruitingCity of Hope Medical Center92023-06-022026-10-01
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Atezolizumab, Bevacizumab, External Beam Radiation Therapy - Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic852019-09-192026-10-05
Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Filgrastim - Plasma Cell Leukemia in Remission, Plasma Cell Myeloma
Phase 1 / Phase 2WithdrawnCity of Hope Medical Center2018-01-012017-12-13
Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma
Cryosurgery, Pembrolizumab, Pheresis - Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7
Phase 1 / Phase 2TerminatedMayo Clinic72017-11-152025-06-12

Conditions studied

Leukemia, Myeloid, Acute (2)  ·  Myelodysplastic Syndromes (2)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Fallopian Tube Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Melanoma (1)  ·  Multiple Myeloma (1)  ·  Myeloproliferative Disorders (1)  ·  Ovarian Neoplasms (1)

Sponsors

City of Hope Medical Center (3)  ·  Mayo Clinic (3)  ·  Fred Hutchinson Cancer Center (1)

Countries

United States (7)

Top investigators

George Somlo, MD (1)  ·  Lewis R. Roberts, MD, PhD (1)  ·  Lionel Kankeu Fonkoua, MD (1)  ·  Matthew S. Block, M.D., Ph.D. (1)  ·  Matthew S. Block, MD, PhD (1)  ·  Naveed Ali, MD (1)  ·  Tanya Siddiqi (1)  ·  Vaibhav Agrawal, MD (1)

NIH funding

P30CA033572 (2), R01CA266783 (1), R01CA274985 (1), R01CA276313 (1), R01CA294704 (1)